How has been the historical performance of Alkem Lab?

Answer:The historical performance of Alkem Lab shows a consistent growth trajectory in net sales and profitability over the years.

Breakdown:
Alkem Lab's net sales have increased from 8,344.36 Cr in March 2020 to 12,964.52 Cr in March 2025, demonstrating a steady upward trend. The total operating income followed a similar pattern, rising from 8,344.36 Cr in March 2020 to 12,964.52 Cr in March 2025. The company's total expenditure, excluding depreciation, also grew, reaching 10,452.37 Cr in March 2025 from 6,870.97 Cr in March 2020. Operating profit (PBDIT) saw a significant increase from 1,577.61 Cr in March 2020 to 3,005.89 Cr in March 2025, indicating improved operational efficiency. Profit before tax rose from 1,259.79 Cr in March 2020 to 2,527.03 Cr in March 2025, while profit after tax increased from 1,149.31 Cr to 2,216.00 Cr over the same period. The company's earnings per share (EPS) also grew substantially, from 94.28 in March 2020 to 181.14 in March 2025. On the balance sheet, total assets increased from 9,012.97 Cr in March 2020 to 15,952.85 Cr in March 2025, while total liabilities rose from 9,012.97 Cr to 15,952.85 Cr. The cash flow from operating activities improved from 585.00 Cr in March 2020 to 1,912.00 Cr in March 2025, although the net cash outflow was recorded at -186.00 Cr in March 2025. Overall, Alkem Lab has shown robust growth in sales, profits, and assets, reflecting a strong financial performance over the years.